- Home
- ORMP
as 07-26-2024 4:00pm EST
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
| Founded: | 2002 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 103.2M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 91.9K |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.26 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.67 - $3.67 | Next Earning Date: | 08-08-2024 |
| Revenue: | $674,000 | Revenue Growth: | -75.06% |
| Revenue Growth (this year): | -42.91% | Revenue Growth (next year): | 433.33% |
Latest Oramed Pharmaceuticals Inc. News
ORMP Breaking Stock News: Dive into ORMP Ticker-Specific Updates for Smart Investing
MT Newswires
a month ago
Oramed Pharmaceuticals Board Approves $20 Million Share-Buyback Program
PR Newswire
a month ago
Oramed Letter to Shareholders
PR Newswire
a month ago
Oramed Pharmaceuticals Inc. Announces the Buy-Back of its Common Stock
Zacks Small Cap Research
2 months ago
ORMP: Moving Oral Delivery Platform Forward, + Potential to Generate Royalties
Simply Wall St.
2 months ago
Oramed Pharmaceuticals First Quarter 2024 Earnings: EPS: US$0.038 (vs US$0.085 loss in 1Q 2023)
Associated Press Finance
3 months ago
Oramed: Q1 Earnings Snapshot
GlobeNewswire
4 months ago
Scilex Holding Company Announces Repayment in Full of the Remaining Balance of Convertible Debentures and Early Payment of the Senior Secured Promissory Note, Paving the Way for Future Growth and Innovation
Simply Wall St.
5 months ago
Oramed Pharmaceuticals Full Year 2023 Earnings: Beats Expectations
Compare ORMP vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ORMP Oramed Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.